Shandong Weigao Group Medical Polymer Company Limited

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 2276.HK has a market cap of 12.00B. Regarding current trading prices, 1066.HK is priced at $5.89, while 2276.HK trades at $24.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 2276.HK's P/E ratio is 22.64. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 2276.HK's ROE of +0.25%. Regarding short-term risk, 1066.HK is less volatile compared to 2276.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 6699.HK has a market cap of 9.29B. Regarding current trading prices, 1066.HK is priced at $5.89, while 6699.HK trades at $54.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 6699.HK's P/E ratio is 101.20. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 6699.HK's ROE of +0.03%. Regarding short-term risk, 1066.HK is less volatile compared to 6699.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 9997.HK has a market cap of 8.84B. Regarding current trading prices, 1066.HK is priced at $5.89, while 9997.HK trades at $7.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 9997.HK's P/E ratio is 14.15. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 9997.HK's ROE of +0.23%. Regarding short-term risk, 1066.HK is less volatile compared to 9997.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 1501.HK has a market cap of 4.52B. Regarding current trading prices, 1066.HK is priced at $5.89, while 1501.HK trades at $25.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 1501.HK's P/E ratio is 21.81. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 1501.HK's ROE of +0.11%. Regarding short-term risk, 1066.HK is more volatile compared to 1501.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 3600.HK has a market cap of 3.79B. Regarding current trading prices, 1066.HK is priced at $5.89, while 3600.HK trades at $4.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 3600.HK's P/E ratio is 9.35. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 3600.HK's ROE of +0.15%. Regarding short-term risk, 1066.HK is more volatile compared to 3600.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 6929.HK has a market cap of 3.11B. Regarding current trading prices, 1066.HK is priced at $5.89, while 6929.HK trades at $3.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 6929.HK's P/E ratio is 9.95. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 6929.HK's ROE of +0.10%. Regarding short-term risk, 1066.HK is less volatile compared to 6929.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 1358.HK has a market cap of 1.59B. Regarding current trading prices, 1066.HK is priced at $5.89, while 1358.HK trades at $1.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 1358.HK's P/E ratio is 10.40. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 1358.HK's ROE of +0.04%. Regarding short-term risk, 1066.HK is more volatile compared to 1358.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 1120.HK has a market cap of 455.79M. Regarding current trading prices, 1066.HK is priced at $5.89, while 1120.HK trades at $1.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 1120.HK's P/E ratio is 39.33. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 1120.HK's ROE of +0.02%. Regarding short-term risk, 1066.HK is more volatile compared to 1120.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 1942.HK has a market cap of 388.81M. Regarding current trading prices, 1066.HK is priced at $5.89, while 1942.HK trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 1942.HK's P/E ratio is -1.79. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 1942.HK's ROE of -0.10%. Regarding short-term risk, 1066.HK is more volatile compared to 1942.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 0907.HK has a market cap of 210.36M. Regarding current trading prices, 1066.HK is priced at $5.89, while 0907.HK trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 0907.HK's P/E ratio is -3.44. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 0907.HK's ROE of -5.79%. Regarding short-term risk, 1066.HK is less volatile compared to 0907.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 0876.HK has a market cap of 121.01M. Regarding current trading prices, 1066.HK is priced at $5.89, while 0876.HK trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 0876.HK's P/E ratio is -2.40. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 0876.HK's ROE of -0.10%. Regarding short-term risk, 1066.HK is less volatile compared to 0876.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1066.HK.

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 26.64B. In comparison, 1134.HK has a market cap of 90.00M. Regarding current trading prices, 1066.HK is priced at $5.89, while 1134.HK trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.27, whereas 1134.HK's P/E ratio is -4.50. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 1134.HK's ROE of -0.13%. Regarding short-term risk, 1066.HK is less volatile compared to 1134.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1066.HK.